Timber Pharmaceuticals Acquires Timber Pharmaceuticals

Timber Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. Timber's investigational therapies have proven mechanisms of action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing, and control) and safety profiles. Timber is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), tuberous sclerosis complex (TSC), and localized scleroderma. Timber Pharmaceuticals is based in Woodcliff Lake, New Jersey.